Researchers from The Cancer Institute of New Jersey (CINJ) have identified candidate drugs that block a key protein responsible for tumor growth. Their research was presented at the recent Annual Meeting of the American Association for Cancer Research (AACR) which I had the good fortune to attend. As we know the common treatment for localized [...]
The American Cancer Society’s Pinellas County branch canceled an LGBT-focused Relay For Life that was scheduled for March 21, 2010. As described by the event’s organizer, Bobby Poth, American Cancer Society officials “ were worried about how the general public would react to an LGBT-targeted event [and] allowed personal beliefs to play a role in [...]
More news from the AACR Annual Meeting Cruciferous vegetables, we all know them and some of us love them. What we know is that they need to form a part of the standard prostate cancer diet, but some early research shows that a substance found in the them can make prostate cancer cells even more [...]
ABC News has posted a brief story about Provenge. Most of us hope that sometime this week the FDA will finally approve Provenge. To see the brief video interview about Provenge click here. Joel T Nowak, MA, MSW
More from my explorations at the American Association of Cancer Researchers (AACR) conference in Washington, D.C. Abstract 5386 described a study using a thalidomide analogue called lenalidomide (Revlimid), in combination with Taxotere, which currently is the only approved drug for chemotherapy for advanced, metastatic castrate resistant prostate cancer. […]